Literature DB >> 31836683

The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging.

Enrico Fantoni1, Lyduine Collij2, Isadora Lopes Alves2, Christopher Buckley1, Gill Farrar.   

Abstract

Although clinical routine focuses on dichotomous and visual interpretation of amyloid PET, regional image assessment in research settings may yield additional opportunities. Understanding the regional-temporal evolution of amyloid pathology may enable earlier identification of subjects in the Alzheimer Disease pathologic continuum, as well as a finer-grained assessment of pathology beyond traditional dichotomous measures. This review summarizes current research in the detection of regional amyloid deposition patterns and its potential for staging amyloid pathology. Pathology studies, cross-sectional and longitudinal PET-only studies, and comparative PET and autopsy studies are included. Despite certain differences, cortical deposition generally precedes striatal pathology, and in PET-only studies, medial cortical regions are seen to accumulate amyloid earlier than lateral regions. Based on regional amyloid PET, multiple studies have developed and implemented models for staging amyloid pathology that could improve subject selection into secondary prevention trials and visual assessment in clinical routine.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  amyloid PET; pathology; spatial-temporal ordering; staging

Year:  2019        PMID: 31836683     DOI: 10.2967/jnumed.119.235879

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

Review 1.  Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.

Authors:  Rachel F Buckley
Journal:  Neurotherapeutics       Date:  2021-03-29       Impact factor: 7.620

2.  Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78-94.

Authors:  Malgorzata M Michalowska; Karl Herholz; Rainer Hinz; Chinenye Amadi; Lynn McInnes; Jose M Anton-Rodriguez; Thomas K Karikari; Kaj Blennow; Henrik Zetterberg; Nicholas J Ashton; Neil Pendleton; Stephen F Carter
Journal:  Mol Psychiatry       Date:  2022-07-20       Impact factor: 13.437

3.  Multitracer model for staging cortical amyloid deposition using PET imaging.

Authors:  Lyduine E Collij; Fiona Heeman; Gemma Salvadó; Silvia Ingala; Daniele Altomare; Arno de Wilde; Elles Konijnenberg; Marieke van Buchem; Maqsood Yaqub; Pawel Markiewicz; Sandeep S V Golla; Viktor Wottschel; Alle Meije Wink; Pieter Jelle Visser; Charlotte E Teunissen; Adriaan A Lammertsma; Philip Scheltens; Wiesje M van der Flier; Ronald Boellaard; Bart N M van Berckel; José Luis Molinuevo; Juan Domingo Gispert; Mark E Schmidt; Frederik Barkhof; Isadora Lopes Alves
Journal:  Neurology       Date:  2020-07-16       Impact factor: 9.910

4.  Amyloid-Associated Depression-or Not?

Authors:  Christopher H van Dyck; Ryan S O'Dell; Adam P Mecca
Journal:  Biol Psychiatry       Date:  2021-04-15       Impact factor: 12.810

5.  Relationship between comprehensive geriatric assessment and amyloid PET in older persons with MCI.

Authors:  Fulvio Lauretani; Livia Ruffini; Maura Scarlattei; Marcello Maggio
Journal:  BMC Geriatr       Date:  2020-09-09       Impact factor: 3.921

6.  Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study.

Authors:  Bernard J Hanseeuw; Vincent Malotaux; Laurence Dricot; Lisa Quenon; Yves Sznajer; Jiri Cerman; John L Woodard; Christopher Buckley; Gill Farrar; Adrian Ivanoiu; Renaud Lhommel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-29       Impact factor: 9.236

7.  Early detection of amyloid load using 18F-florbetaben PET.

Authors:  Santiago Bullich; Núria Roé-Vellvé; Marta Marquié; Susan M Landau; Henryk Barthel; Victor L Villemagne; Ángela Sanabria; Juan Pablo Tartari; Oscar Sotolongo-Grau; Vincent Doré; Norman Koglin; Andre Müller; Audrey Perrotin; Aleksandar Jovalekic; Susan De Santi; Lluís Tárraga; Andrew W Stephens; Christopher C Rowe; Osama Sabri; John P Seibyl; Mercè Boada
Journal:  Alzheimers Res Ther       Date:  2021-03-27       Impact factor: 6.982

8.  Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging.

Authors:  Isadora Lopes Alves; Fiona Heeman; Lyduine E Collij; Gemma Salvadó; Nelleke Tolboom; Natàlia Vilor-Tejedor; Pawel Markiewicz; Maqsood Yaqub; David Cash; Elizabeth C Mormino; Philip S Insel; Ronald Boellaard; Bart N M van Berckel; Adriaan A Lammertsma; Frederik Barkhof; Juan Domingo Gispert
Journal:  Alzheimers Res Ther       Date:  2021-04-19       Impact factor: 6.982

9.  White matter microstructure disruption in early stage amyloid pathology.

Authors:  Lyduine E Collij; Silvia Ingala; Herwin Top; Viktor Wottschel; Kristine E Stickney; Jori Tomassen; Elles Konijnenberg; Mara Ten Kate; Carole Sudre; Isadora Lopes Alves; Maqsood M Yaqub; Alle Meije Wink; Dennis Van 't Ent; Philip Scheltens; Bart N M van Berckel; Pieter Jelle Visser; Frederik Barkhof; Anouk Den Braber
Journal:  Alzheimers Dement (Amst)       Date:  2021-04-01

10.  Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals.

Authors:  Lyduine E Collij; Sophie E Mastenbroek; Gemma Salvadó; Alle Meije Wink; Pieter Jelle Visser; Frederik Barkhof; Bart N M van Berckel; Isadora Lopes Alves
Journal:  Alzheimers Dement (Amst)       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.